Geetesh Devineni, Graduate Student, Kostal Lab & Ben England, Graduate Student, Dowd Lab, Graduate Students, GW Department of Chemistry

Fri, 10 March, 2023 2:00pm - 3:00pm

The Department of Chemistry Presents, via Online and In-person Presentation: Geetesh Devineni, Graduate Student, Kostal Lab & Ben England, Graduate Student, Dowd Lab, Graduate Students, GW Department of Chemistry

Geetesh Devineni, Graduate Student, Kostal Lab

Geetesh Devineni, Graduate Student, Kostal Lab, GW Department of Chemistry

The many applications of in silico modeling: from polymer chemistry to predicting chemical behavior in the environment to designing safer, biobased agrochemicals

There is growing need to move towards a more sustainable economy to reduce the negative impact of chemical production on both human and environmental health. Presented here are several projects that leverage in silico methods for the advancement of this goal. The bioconcentration factor (BCF) is a key metric in evaluating sustainability and potential toxicity in the aquatic environment; however, experimental determinations of BCF are expensive and time-consuming. Instead, Quantitative Structure Property Relationships (QSPR’s) can be developed to predict BCF using mechanistically relevant physiochemical properties. Appropriately validated, these models can supplement or, pending regulatory approval, replace economically and ethically unfeasible animal testing. Our approach to BCF prediction, as outlined here, improves on existing models by considering ionization of xenobiotics, which affects both bioavailability and transport to storage sites, and by gauging relevant properties from explicit Monte Carlo simulations in the condensed phase. In a different project, we show how machine learning can be leveraged to develop a workflow for iterative, virtual synthesis of novel (greener) pesticides from renewable building blocks. Bio-based building blocks such as fumaric acid, succinic acid, lysine, or ethanol, were mined from literature and combinatorially reacted to form successive generations of products (i.e., a virtual library of tens of thousands of compounds). Mimicking computer-aided drug discovery, existing insecticides were then used to screen the virtual library for potential leads based on mode of action and relevant physicochemical/thermodynamic properties. Identified leads are subsequently optimized using free energy perturbation calculations and validated experimentally to propose new agrochemicals. Uniquely, our workflow allows for the quantification and reconciliation of the intrinsic underlying tradeoffs between selective toxicity (i.e., performance), unintended toxicity and environmental persistence, a feat that is much harder to accomplish when redesigning existing (petroleum-based) pesticides. Lastly, we present on a collaboration with the Boyes’ polymer chemistry group to explore reactivity differences across different monomers, which have promising applications in well defined, functional, aromatic polyamides. Our studies provide mechanistic understanding of experimental outcomes, with the goal to guide design of novel building blocks with desirable characteristics.  

 

Ben England, Graduate Student, Dowd Lab, GW Department of Chemistry

Staphylococcus-Specific Prodrugs Towards Targeted Antibiotics

Novel antimicrobial therapeutic options have been a pressing need since the discovery of penicillin by Ian Fleming in 1928. Today, the use of penicillin is limited by the increase in resistant pathogens. A contributor to resistance is the broad spectrum of activity that many clinically used antibiotics possess. Broad spectrum antibiotics are known to kill commensal flora, which cultivates resistance phenotypes within the host microbiome. Pathogen-specific antimicrobial options are urgently needed to curb the application of selective pressure that broad spectrum antibiotic use represents.

The goal of genus-specific drug delivery may be attainable with the help of a prodrug strategy in which a clinically relevant broad-spectrum antibiotic can be modified for microbial activation and subsequent targeted killing. We aim to utilize this strategy to target a recently discovered Staphylococcus-specific metabolic enzyme for prodrug activation, GloB. To this end, we have demonstrated the capacity of this enzyme to activate prodrugs of antibiotics we have synthesized and have used in vitro ligand screens as well as virtual screens to inform the design of future GloB-specific prodrugs.

Bio

Ben graduated with a B.A. in chemistry from McDaniel College in Westminster, MD in 2019. His research in medicinal chemistry under Dr. Cynthia Dowd has focused on the synthesis, design, and assessment of novel prodrugs of antibiotics as well as antiparasitic therapies.

 

Where
Science & Engineering Hall 800 22nd Street, NW Washington DC 20052
Room: B1220

Contacts
Chemistry Department
[email protected]
(202) 994-6121

Share This Event